In quest to control migraines, Peninsula company raises $62 million to send drug up your nose

Marrying the old and the new, this South San Francisco company is taking its experimental treatment for acute migraines into a huge late-stage clinical trial.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news